Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amy L. Skversky"'
Autor:
Caroline A. Gluck, Christopher B. Forrest, Amy Goodwin Davies, Mitchell Maltenfort, Jill R. Mcdonald, Mark Mitsnefes, Vikas R. Dharnidharka, Bradley P. Dixon, Joseph T. Flynn, Michael J. Somers, William E. Smoyer, Alicia Neu, Collin A. Hovinga, Amy L. Skversky, Thomas Eissing, Andreas Kaiser, Stefanie Breitenstein, Susan L. Furth, Michelle R. Denburg
Publikováno v:
Clinical Journal of the American Society of Nephrology. 18:173-182
Autor:
Larry A. Greenbaum, Craig B. Langman, Michael F. Schneider, Marva Moxey-Mims, Lucy Mulqueen, Oleh Akchurin, Frederick J. Kaskel, Ellen R. Brooks, Susan L. Furth, Bradley A. Warady, Amy L. Skversky
Publikováno v:
Clinical Journal of the American Society of Nephrology. 9:1519-1525
Background and objectives Poor growth is a consequence of CKD, but can often be partially or fully prevented or corrected with the use of a number of medications. The extent of nonadherence with medications used to treat or mitigate growth failure in
Autor:
Lauren Weintraub, Samriti Dogra, Amy L. Skversky, Ljiljana V. Vasovic, Joan Uehlinger, Manpreet Ahluwalia
Publikováno v:
Clinical Nephrology. Case Studies
Hemolytic uremic syndrome (HUS) secondary to Streptococcus pneumoniae infections (pHUS) has been well reported in the literature and accounts for roughly 5% of all the cases of HUS. However, this condition is likely under-diagnosed and the incidence
Autor:
Eduardo Perelstein, Amy L. Skversky, Ibrahim F. Shatat, Juhi Kumar, Valerie L. Johnson, Shefali Mahesh, Marcela Del Rio, Robert P. Woroniecki
Publikováno v:
Pediatric Nephrology. 28:333-338
Focal segmental glomerulosclerosis (FSGS) recurs in 20-40 % of allografts. Plasmapheresis (TPE) has been one of the mainstays of treatment with variable results. Rituximab (RTX), a monoclonal antibody to the protein CD20, is being used for treatment
Autor:
Harini Sarathy, Juhi Kumar, Gabriela Henriquez, Tanya S. Johns, Sylvia E. Rosas, Michal L. Melamed, Amy L. Skversky, Matthew K. Abramowitz, Frederick J. Kaskel, Holly Kramer
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 5, p e0153588 (2016)
PLoS ONE, Vol 11, Iss 5, p e0153588 (2016)
Objective Kidney dysfunction in obesity may be independent of and may precede the development of hypertension and/or diabetes mellitus. We aimed to examine if abdominal obesity is associated with early markers of CKD in a young healthy population and
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 96:3838-3845
In many disorders requiring steroid therapy, there is substantial decrease in bone mineral density. The association between steroid use and 25-hydroxyvitamin D [25(OH)D] deficiency has not been confirmed in large population-based studies, and current
Autor:
Susan L. Furth, Juhi Kumar, Thomas Jemielita, Ellen R. Brooks, Bradley A. Warady, Mary B. Leonard, Isidro B. Salusky, Anthony A. Portale, Michelle R. Denburg, Amy L. Skversky
Childhood chronic kidney disease (CHD) poses multiple threats to bone accrual; however, the associated fracture risk is not well characterized. This prospective cohort study included 537 CKD in Children (CKiD) participants. Fracture histories were ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64b814242f25bb57c2bd9f91c58e5646
https://europepmc.org/articles/PMC4731126/
https://europepmc.org/articles/PMC4731126/
Autor:
Stephanie L. Clark, Lisa M. Satlin, Sarah J. Swartz, Amy L. Skversky, Victoria F. Norwood, Tamar Springel, H. William Schnaper, David S. Hains, Kathryn G. Schubert, Jesse L. Roach, Sharon A. Perlman, John David Spencer
Publikováno v:
The Journal of pediatrics. 166(2)